Wikipedia -WSS

Wikipedia

author：knowledge 2025-10-01 02:28:10 - browse：9

Earlier this month, Intellia Therapeutics announced it was scrapping plans to include U.S.-based sites in one of its mid-stage CRISPR trials after the Food and Drug Administration requested additional data to support including female patients of childbearing potential. The move left many researchers wondering whether the specter of accidental germline transmission — which haunted early gene therapy trials — had now risen over the field of gene editing.

Over the weekend, Intellia sought to assure the gene editing community that no such thing is happening. At a meeting at Cold Spring Harbor Laboratory that drew more than 400 of the field’s top scientists, the company shared more detailed information about studies it has conducted to assess the risks that renegade CRISPR components could be getting into an egg or sperm. These studies demonstrate “that there’s no evidence of vertical germline transmission of those edits,” Jonathan Phillips, head of pharmacology and toxicology at Intellia, said during a presentation Saturday.

Intellia is one of the leading companies working to advance in vivo gene editing therapies. In a landmark study published in the New England Journal of Medicine in 2021, Intellia revealed data from six patients in its trial for a transthyretin amyloidosis therapy — showing for the first time that it was possible to precisely alter the DNA of particular cells within the human body to treat disease with a one-time infusion of CRISPR. Included in the supplementary material was a redacted version of the company’s package requesting authorization to start its clinical trial. It noted that during toxicology studies in non-human primates, Intellia scientists discovered that editing had taken place at low levels in organs other than the liver, including the spleen and adrenal glands. In three out of 12 female monkeys, they also found editing in the animals’ ovaries.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Anthony Fauci pushes back on GOP claims during Covid hearing

WSS

Medicare Advantage's lean provider networks lead CMS complaints

Data don't support strong claims for Covid

The response to Covid

A new initiative will help leaders fight the next pandemic

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Sutter Health’s antitrust win overturned by appeals court

leisure time

Wikipedia

explore

Medical records are filled with copy

FDA approves first blood sugar monitor without finger pricks

23andMe had bad news about my health. I wish a person had delivered it

New requirements coming in 2024 for Americans traveling to Europe

Walensky prepares to leave CDC — and Congress — behind

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Continuity nursing helped my family in our darkest PICU moments

FDA approves first blood sugar monitor without finger pricks

Apple is now the first public company to be valued at $3 trillion

An outdated Medicare rule harms dementia patients with anxiety

focus

What Henrietta Lacks's story taught me about my role as a doctor

PrEP can help anyone prevent HIV. Why do so few people take it?

Elevance PBM president out as customers face prescription chaos

Sutter Health’s antitrust win overturned by appeals court

Clinic falsely told dozens they had Alzheimer's, suits say

Stopping antidepressants leads to symptoms for 1 in 6 patients

knowledge

leisure time

focus

focus